Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.9049
-0.0146 (-1.59%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9175
+0.0126 (1.39%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $115.15 million as of September 4, 2026. Its market cap has increased by 42.68% in one year.
Market Cap
115.15M
Enterprise Value
58.94M
1-Year Change
42.68%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $115.15M, a decrease of -1.61%. That is a compound annual growth rate of -0.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 115.15M | -53.25% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 121.80M |
| Cibus | 121.52M |
| Rani Therapeutics Holdings | 120.62M |
| Aardvark Therapeutics | 117.74M |
| Connect Biopharma Holdings | 115.87M |
| ProMIS Neurosciences | 112.99M |
| Coya Therapeutics | 111.66M |
| Tenax Therapeutics | 111.13M |